Astera Labs (NASDAQ:ALAB) Stock Price Down 6.9% – Should You Sell?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price dropped 6.9% during trading on Friday . The company traded as low as $304.15 and last traded at $304.5240. Approximately 396,418 shares were traded during trading, a decline of 93% from the average daily volume of 5,525,582 shares. The stock had previously closed at $326.97.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Royal Bank Of Canada lifted their price target on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, May 6th. TD Cowen raised their target price on shares of Astera Labs from $225.00 to $425.00 and gave the stock a “hold” rating in a research report on Monday, July 13th. UBS Group raised their target price on shares of Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a research report on Monday, June 29th. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Finally, Morgan Stanley increased their price target on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $282.00.

Astera Labs Stock Performance

The stock’s 50-day moving average price is $358.95 and its two-hundred day moving average price is $225.66. The stock has a market capitalization of $49.98 billion, a PE ratio of 197.01, a P/E/G ratio of 3.38 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same period last year, the company posted $0.33 EPS. Astera Labs’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts predict that Astera Labs, Inc. will post 1.86 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Manuel Alba sold 8,491 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total value of $3,892,104.58. Following the sale, the director owned 286,863 shares in the company, valued at $131,492,261.94. This represents a 2.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,676,845 shares of company stock worth $444,928,806 over the last three months. Corporate insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently modified their holdings of the stock. Eurizon Capital SGR S.p.A. purchased a new position in shares of Astera Labs in the fourth quarter worth $18,708,000. Nordea Investment Management AB purchased a new stake in shares of Astera Labs during the fourth quarter valued at $2,028,000. Swedbank AB boosted its position in shares of Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after buying an additional 33,940 shares during the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new stake in Astera Labs in the 4th quarter worth about $499,000. Finally, Revere Asset Management Inc bought a new stake in Astera Labs in the 4th quarter worth about $589,000. 60.47% of the stock is currently owned by institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.